2023-2029 Global Gene Fragment Synthesis Industry Research & Trends Analysis Report

According to YH Research, the global market for Gene Fragment Synthesis should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Gene Fragment Synthesis market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Gene Fragment Synthesis market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, 0-999 bp segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, CRISPR-based Genome Editing has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Gene Fragment Synthesis include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, Twist Bioscience, Synbio Technologies, Bio Basic and BiOligo Biotechnology, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
This report aims to provide a comprehensive study of the global market for Gene Fragment Synthesis. Report Highlights:
(1) Global Gene Fragment Synthesis market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Gene Fragment Synthesis market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Gene Fragment Synthesis market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Gene Fragment Synthesis segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Gene Fragment Synthesis segment by type and by application and regional segment by type and by application.
(6) Gene Fragment Synthesis industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
Market segment by application, can be divided into
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
Market segment by players, this report covers
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology